Diane Hendricks serves as Executive at Monopar Therapeutics, where they oversee executive responsibilities. Since joining the company, Diane Hendricks has executed 2 insider transactions totaling $3.8M, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 16, 2025 involved transacting 43,499 shares valued at $0.
Diane Hendricks currently holds 567,580 shares of Monopar Therapeutics (MNPR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Diane Hendricks has been a net buyer of MNPR stock. They have purchased $3.8M and sold $0 worth of shares.
Diane Hendricks's most recent insider trade was on Dec 16, 2025, when they sold 43,499 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $8.00 |
| Discretionary |